Arkolith/Insider Trading/DNLI/Form 4

Sato Vicki L

DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Nov 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$83K
Net Open-Market Flow
-$83K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2024Sell(S)3K$27.07$83K112K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-24-000208) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML